Search results for "HPV"
Raising awareness about HPV-related cancers
The human papillomavirus (HPV) vaccine can potentially prevent more than 90% of HPV-associated cancers. Generally given to teens, it can be offered to adults as well.
https://immattersacp.org/archives/2023/10/raising-awareness-about-hpv-related-cancers.htm
1 Oct 2023
Home-based HPV screening appears cost-effective, study finds
In an economic evaluation of 19,851 female participants from a randomized clinical trial, incremental cost-effectiveness ratios for increased uptake of human papillomavirus (HPV) screening ranged from $86 to $146 per additional screening completed.
https://immattersacp.org/weekly/archives/2023/03/28/4.htm
28 Mar 2023
Decrease in certain HPV types among unvaccinated women suggests herd protection
Prevalence of the four types of human papillomavirus (HPV) included in the original vaccine decreased most among women who were fully vaccinated but also decreased significantly among women who were unvaccinated between 2006 and 2017.
https://immattersacp.org/weekly/archives/2019/01/29/4.htm
29 Jan 2019
HPV vaccine impacts disease, screening
While HPV immunization is recommended during adolescence, internists practicing in the postvaccine era have their own host of considerations: namely, screening for cervical cancer and providing catch-up vaccination.
https://immattersacp.org/archives/2017/02/hpv.htm
1 Feb 2017
HPV testing compared with cytology may result in less cervical intraepithelial neoplasia
Clinicians will have to choose between primary human papillomavirus testing and co-testing based on modeling and cost-effectiveness studies, an editorial noted.
https://immattersacp.org/weekly/archives/2018/07/10/2.htm
10 Jul 2018
HPV vaccine efficacy increases, but use lags
Human papillomavirus immunization rates continue, for several reasons, to lag behind those of other vaccines. Experts are formulating new approaches for physicians and patients to ensure that HPV protection is as robust as possible.
https://immattersacp.org/archives/2016/02/HPV.htm
1 Feb 2016
Little health benefit, higher costs likely with extended age limit for HPV vaccination
A modeling study examined four scenarios for extended vaccination in women and men up to ages 26, 30, 40, and 45 years.
https://immattersacp.org/weekly/archives/2019/12/10/1.htm
10 Dec 2019
HPV vaccination now impacts practice later
This issue covers such topics as HPV vaccination, news from ObesityWeek, and a preview of upcoming events at Internal Medicine Meeting 2017.
https://immattersacp.org/archives/2017/02/editors.htm
1 Feb 2017
CDC recommends change to HPV vaccination schedule
Three doses had previously been recommended, but studies have suggested that 2 doses are just as effective in children who begin vaccination before age 15, the CDC's Advisory Committee on Immunization Practices decided.
https://immattersacp.org/weekly/archives/2016/10/25/5.htm
25 Oct 2016
Cervical cancer screening may be able to occur later, less often in HPV-vaccinated women, study suggests
When compared with no intervention, vaccination alone with no screening produced a 64.6% mean reduction in lifetime cervical cancer risk, and screening strategies increased this risk reduction to a range of 88% to 98%. The lowest cost-effectiveness ratio was seen with cytology-only screening every 5 years starting at age 35, compared with vaccination alone.
https://immattersacp.org/weekly/archives/2016/10/25/4.htm
25 Oct 2016